HANNAH HOOTEN: Open Payments
NPI 1275291635 · SANTA ROSA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 61 payments from 30 companies in 2025. Trend: 2023 $1,079 · 2024 $2,040 · 2025 $1,430
Food & beverage: $1,330Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $116 |
| GlaxoSmithKline, LLC. | 6 | $110 |
| Exelixis Inc. | 1 | $100 |
| Incyte Corporation | 4 | $98 |
| Genentech USA, Inc. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| ARRAY BIOPHARMA INC | 3 | $55 |
| Celgene Corporation | 2 | $52 |
Products named: BRUKINSA, AYVAKIT, OJJAARA, Venclexta, KEYTRUDA, REBLOZYL, Orserdu, JAKAFI.
Industry payments across FL — which companies pay providers there.
